Navigation Links
Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results
Date:5/7/2008

CTI with direct responsibilities for development and

commercial operations, effective August 1, 2008

o Restructured, or retired more than $66 million of current convertible

debt and preferred securities while raising over $50 million in gross

proceeds during the past two quarters

Conference Call Information

On Thursday, May 8, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific members of Cell Therapeutics, Inc.'s (CTI) (NASDAQ: CTIC and MTA: CTIC) management team will host a quarterly conference call to discuss the company's 2008 first quarter achievements and financial results.

Conference Call Numbers

Thursday, May 8

8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time

1-877-835-3295 (US Participants)

1-303-262-2137 (International)

Call-back numbers for post-listening available at 11:30 a.m. Eastern:

1-800-405-2236 (US Participants)

1-303-590-3000 (International)

Passcode: 11114025#

Live audio webcast at http://www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.CellTherapeutics.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual futur
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
2. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
3. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
4. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
5. Profarmas Gross Revenues Reached R$ 702.6 Million in the 1st Quarter 2008, a 26.5% Growth Over the Same Period Last Year
6. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
7. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
8. MEDRAD(R) Revenues Grow 10 Percent in 2007
9. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
10. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
11. Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... York, NY (PRWEB) May 22, 2013 A ... Public Health has found that of young people who visited ... girls and youth who were obese were more likely to ... food choices. It also found that young people eating at ... were half as likely to use calorie information as those ...
(Date:5/22/2013)... CHARLOTTE, (PRWEB) May 22, 2013 The ... fight against muscular dystrophy at the annual Charlotte Muscle ... $300,000 to help Charlotte-area families living with muscle disease. ... this year's event to support MDA families,” said MDA ... heroes who were partnered with a "Buddy" to make ...
(Date:5/22/2013)... is a gender gap when it comes to behavior ... does not appear to exist in children in Asia. ... of self-regulation than boys. Self-regulation is defined as children,s ... and persist on a task. It has been linked ... by Oregon State University researchers. , In three ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 ... of the DePuy Pinnacle Hip Replacement System continue to ... Federal Court, Bernstein Liebhard LLP reports. According to ... DePuy Orthopaedics to produce monitoring reports associated with a ... company’s medical device marketing practices. Plaintiffs maintained in ...
(Date:5/22/2013)... May 22, 2013 Twenty student-led startup ... year participating in an intensive startup accelerator designed to ... or services and create local jobs as part of ... year the Edson initiative offers approximately 20 student teams ... mentorship and training to launch their for-profit, more-than-profit or ...
Breaking Medicine News(10 mins):Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9
... to autism. A study in this week's issue of ... more likely than those without it to have had ... Boston University identified 90 children with autism and compared ... medical histories, including when they had the measles, mumps, ...
... vision loss with lazy eye, but not in the eye affected ... loss in the normal eye in the future.// At least 2 ... eye. ,Many countries routinely screen for lazy eye. The ... that eye. Some, but not all, countries place high importance on ...
... their recent study compare between bypass surgery and stenting ... options for blocked coronary arteries. //Bypass surgery involves grafting ... Stenting involves introducing a metal device into the artery ... a group of 200 patients to either minimally-invasive bypass ...
... are given antibiotics after being hospitalized have a lower risk of ... from Croydon Hospital, England //say that the reduced risk was ... a role in heart disease. The effect was seen regardless of ... pylori or Chlamydia pneumoniae. ...
... one handful of almonds a day may improve your ... the risk of coronary heart disease by lowering cholesterol.// ... are generally not recommended for people who need to ... determine if almonds can reduce heart disease risk by ...
... survey observe that many people are still not very much aware ... account for about 4% of all malignancies. //The warning signs can ... a cure. But, as a survey by dental experts at New ... ,The survey was part of a three day oral cancer ...
Cached Medicine News:Health News:Almonds Improve Cholesterol 2
(Date:5/22/2013)... 2013 The new 13-valent pneumococcal conjugate vaccine ... version used prior to 2010, the 7-valent pneumococcal conjugate ... today in Vaccine. The U.S. Food and ... after a series of trials. These trials found that ... types than the previously used PCV7, did not increase ...
(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...
(Date:5/22/2013)... 22, 2013  MGT Capital Investments, Inc. (NYSE MKT: ... the Second Annual Marcum LLP MicroCap Conference on Thursday, ... at the Grand Hyatt Hotel.  ... will update investors and answer questions. (Logo: ... is scheduled to begin at 9:30 a.m. EDT.  MGT,s ...
Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4
... 11 Caraco Pharmaceutical Laboratories, Ltd. (NYSE: ... and 100mg oxaliplatin injections, which are therapeutically equivalent to ... and Drug Administration (FDA) for Sun Pharma,s Abbreviated New ... the treatment of colon and rectal cancer. Oxaliplatin injections ...
... SANTA MARIA, Calif. , March 11 ... the Snap-On Smile® brand and all intellectual property surrounding ... LUMINEERS® Smile Design Studio, an ISO 9001 certified laboratory ... services.  For over 30 years, DenMat has been providing ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition 2DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition 3DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: